Show simple item record

dc.contributor.authorFransen L
dc.contributor.authorNsanze H
dc.contributor.authorNdinya-Achola JO
dc.contributor.authorD'Costa L
dc.contributor.authorRonald AR
dc.contributor.authorPiot P
dc.date.accessioned2013-06-11T06:39:48Z
dc.date.available2013-06-11T06:39:48Z
dc.date.issued1987-06
dc.identifier.citationSex Transm Dis. 1987 Apr-Jun;14(2):98-101.en
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/2956702
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/31116
dc.description.abstractIn a controlled trial 32 patients with ulcers culture-positive for Haemophilus ducreyi were treated with a single 2-g dose of spectinomycin, and 20 patients were treated with a five-day course of trimethoprim-sulfamethoxazole (TMP-SMZ; 160/800 mg) twice daily. Both regimens rapidly eradicated H. ducreyi from ulcers, with subsequent healing of ulcers and buboes. The cure rates 14 days after initiation of therapy were 94% for spectinomycin and 95% for TMP-SMZ. Patients with H. ducreyi-negative ulcers who were treated with the same regimens also healed and did not show a significantly different efficacy for either regimen. Thus we found that the one-day regimen of spectinomycin was as effective for the treatment of chancroid as was TMP-SMZ given for five days. Further studies on a larger number of patients are needed to confirm our findings.en
dc.language.isoenen
dc.publisherUniversity of Nairobien
dc.titleA comparison of single-dose spectinomycin with five days of trimethoprim-sulfamethoxazole for the treatment of chancroiden
dc.typeArticleen
local.publisherDepartment of Medicineen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record